2m 2m 2m 2m 2m 2m 2m
ADDEX THERAP SP ADS (ADXN)
NASDAQ
$4.63-$0.31 (-6.26%)
Price as of Aug 21, 2026 7:59 PM EDT- $6.3MMarket Cap
- -43.41%1-Year Change
- BiotechnologyIndustry
ADDEX THERAP SP ADS (ADXN)
$4.63-$0.31 (-6.26%)
ADXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.94 | ||
Change | +$0.37 (+8.10%) | ||
Open | $5.87 | ||
High | $6.05 | ||
Low | $4.60 | ||
Previous Close | $4.57 | ||
Volume | 7,270,693 | ||
30-Day Average Volume | 837,068 | ||
1-Week Change | -16.97% | ||
1-Month Change | -16.20% | ||
1-Year Change | -43.41% | ||
3-Year Change | -49.77% | ||
5-Year Change | -97.50% | ||
Fundamentals | |||
Shares Outstanding | 1.3M | ||
Total Assets | $6.4M | ||
Market Cap | $6.3M | ||
Enterprise Value | $4.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/23/2023 | ||
Earnings & Revenue